[吸入药物的气候意识的处方]
Guido Schmiemann1, Michael Dörks2, Christian Grah3
1Abteilung für Versorgungsforschung, Fachbereich 11 Institut für Public Health und Pflegeforschung, Universität Bremen, Bremen, Deutschland.
Pneumologie (Stuttgart, Germany)
|May 13, 2025
概括
本指南促进了对吸入药物的气候意识的处方,以减少医疗保健.
科学领域:
- 环境健康 环境健康
- 呼吸系统医学 呼吸系统医学
- 公共卫生政策 公共卫生政策
背景情况:
- 气候变化对患有喘和COPD等慢性呼吸道疾病的个人构成风险.
- 吸入药物虽然对治疗至关重要,但通过计量剂量吸入器 (MDIs) 中的强效温室气体推进剂,它们对全球变暖有所贡献.
- 干粉吸入器 (DPI) 被认为是MDIs更环保的替代品.
研究的目的:
- 通过气候意识的吸入疗法的处方来减少医疗保健系统的碳足迹.
- 根据环境影响和个体患者因素,为选择吸入系统提供指导和建议.
- 为阻塞性肺部疾病提供信息并使气候意识的治疗选择成为可能.
主要方法:
- 为处方吸入药物制定临床指导方针.
- 对12岁以上的青少年和患有阻塞性肺病的成年人,偏好干粉吸入器 (DPI) 而不是计量剂量吸入器 (MDI) 的建议.
- 包括决策辅助来解释吸入器类型之间的差异,并强调适当的使用培训.
主要成果:
- 该指南建议适合患者吸入治疗,最好是DPI,以尽量减少排放.
- 它建议在处方时选择用剂量计数器的计量剂量吸入器 (MDIs).
- 如果每年需要使用短效β-agonists (SABAs) 超过两次,这表明疾病控制不佳,则需要进行治疗审查.
结论:
- 采用该指南可以显著减少治疗阻塞性肺部疾病对环境的影响.
- 以患者为中心的吸入器设备的选择,考虑到环境足迹和可用性,至关重要.
- 有效实施需要支持材料,并强调患者和医疗保健提供者的教育.
相关概念视频
Inhaled Medications
205
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
205
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
156
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
156
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Antiasthma Drugs: Methylxanthines
130
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
130
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


